[{"address1": "4660 La Jolla Village Drive", "address2": "Suite 100", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "650 800 3717", "website": "https://www.revbiosciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. James M. Rolke", "age": 55, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 813226, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chester Stanley Zygmont III", "age": 44, "title": "CFO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 564006, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Vedrick", "title": "Vice President of Human Resources & Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carol  Odle", "title": "Senior Director of Clinical Projects", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.76, "open": 2.7, "dayLow": 2.7, "dayHigh": 3.1097, "regularMarketPreviousClose": 2.76, "regularMarketOpen": 2.7, "regularMarketDayLow": 2.7, "regularMarketDayHigh": 3.1097, "payoutRatio": 0.0, "beta": 0.177, "forwardPE": -1.3133048, "volume": 44460, "regularMarketVolume": 44460, "averageVolume": 265678, "averageVolume10days": 267070, "averageDailyVolume10Day": 267070, "bid": 2.2, "ask": 3.53, "bidSize": 2, "askSize": 2, "marketCap": 2769997, "fiftyTwoWeekLow": 2.36, "fiftyTwoWeekHigh": 60.8, "fiftyDayAverage": 4.86512, "twoHundredDayAverage": 14.80796, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -4000588, "profitMargins": 0.0, "floatShares": 859179, "sharesOutstanding": 905228, "sharesShort": 61699, "sharesShortPriorMonth": 63430, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.1181, "heldPercentInsiders": 0.00059999997, "heldPercentInstitutions": 0.0681, "shortRatio": 0.37, "shortPercentOfFloat": 0.1182, "impliedSharesOutstanding": 983944, "bookValue": 9.016, "priceToBook": 0.33939663, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15038536, "trailingEps": -87.68, "forwardEps": -2.33, "lastSplitFactor": "1:16", "lastSplitDate": 1738022400, "enterpriseToEbitda": 0.503, "52WeekChange": -0.92901236, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 3.06, "targetHighPrice": 320.0, "targetLowPrice": 21.45, "targetMeanPrice": 170.725, "targetMedianPrice": 170.725, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 6499018, "totalCashPerShare": 7.179, "ebitda": -7947186, "totalDebt": 0, "quickRatio": 3.396, "currentRatio": 3.431, "returnOnAssets": -0.52928, "returnOnEquity": -2.64854, "freeCashflow": -8343943, "operatingCashflow": -18321276, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "REVB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1605623400000, "regularMarketChange": 0.29999995, "regularMarketDayRange": "2.7 - 3.1097", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 265678, "fiftyTwoWeekLowChange": 0.70000005, "fiftyTwoWeekLowChangePercent": 0.2966102, "fiftyTwoWeekRange": "2.36 - 60.8", "fiftyTwoWeekHighChange": -57.739998, "fiftyTwoWeekHighChangePercent": -0.94967103, "fiftyTwoWeekChangePercent": -92.90124, "earningsTimestamp": 1741295700, "earningsTimestampStart": 1746701940, "earningsTimestampEnd": 1747051200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -87.68, "epsForward": -2.33, "epsCurrentYear": -21.705, "priceEpsCurrentYear": -0.14098133, "fiftyDayAverageChange": -1.80512, "fiftyDayAverageChangePercent": -0.37103298, "twoHundredDayAverageChange": -11.747959, "twoHundredDayAverageChangePercent": -0.79335433, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "regularMarketTime": 1742411646, "exchange": "NCM", "messageBoardId": "finmb_696222591", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 10.869564, "regularMarketPrice": 3.06, "shortName": "Revelation Biosciences, Inc.", "longName": "Revelation Biosciences, Inc.", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]